Loading annual review details
Paychex, Inc. (PAYX)FY2026 investor yearly review
Across FY2026, management moved from early-integration conservatism to measurable cross-sell momentum, while expanding AI from tools into agentic workflows. Q2 and Q3 showed margin and revenue productivity strength; Q4 reinforced trust and higher advisory engagement—supported by strong retention and rising free cash flow.
Overall investor read
Strong execution with AI monetization still early
Management demonstrated solid results and rising cross-sell activity, but AI-driven monetization is framed as an ongoing build.
Primary financial signal
$2.32B free cash flow; 35.7% margin
FY2026 free cash flow and margin stayed strong as management highlighted productivity, cost discipline, and ongoing AI investment.
Primary call signal
AI features scaled; WISE embedded in workflows
Management described WISE powering hundreds of AI features and agents, with early workflow benefits and compliance automation use cases.
Selected metrics summarize Paychex’s full-year operating and cash-flow performance.
Revenue
Revenue growth of 16.9% supported upside momentum through the year.
Revenue growth
Growth accelerated from early integration into back-half momentum.
Gross margin
Gross margin stayed high as management pushed productivity and pricing.
Operating margin
Operating margin reflects cost discipline while funding AI investments.
Diluted EPS
EPS rose 6.8% as earnings guidance was lifted during FY2026.
Free cash flow
Free cash flow rose 32.0% and stayed resilient versus revenue growth.
Free cash flow margin
Cash conversion stayed strong, reinforcing management’s “high-quality” model.
Capital returns
Capital returns continued alongside growth and integration-related investments.
FY2026 evolved from integration execution to confident cross-selling, with AI moving from advisory support to agentic workflow automation.
Acquisition execution
Early in the year, management emphasized integration progress, cost synergy milestones, and pipeline-building for cross-selling into Paycor’s client base. By Q3 and Q4, bookings and broker referrals were described as returning to pre-acquisition levels, with larger-than-expected ASO and broker-referred PEO wins.
Quarter-by-quarter materiality and tone for annual transcript themes.
Scroll horizontally to see more columns.
| Theme | Q1 | Q2 | Q3 | Q4 | Next monitor |
|---|---|---|---|---|---|
| Integration disruption faded as cross-sell momentum broadened | Positive Integration on track; management pushed early ASO/PEO cross-sells. | Positive |
Management’s recurring positives were integration progress turning into repeatable cross-sell, plus AI workflow scaling that supported productivity and cash generation. The recurring challenges were customer value-bundling behavior and near-term PEO/insurance offsets from Florida and agency dynamics.
Management moved from early synergy pipeline building in Q1 toward reaccelerating bookings and broker referrals in Q2–Q3, and then described broader success in Q4 with larger-than-expected deals.
Across four calls, management described expanding AI capabilities—then scaling pilots into voice/email payroll agents and finally positioning WISE with measurable administrative reductions and time savings in Q4.
FY2026 progressed from integration-led confidence to AI-embedded execution, with PEO/insurance growth shaped by enrollment comp cycles and agency drag.
Operating leverage with strong cash conversion
Product breakdown bars are scaled against the largest annual revenue item; labels show revenue, YoY change, and revenue share.
The year’s narrative tightened: integration and cost synergies were achieved early, then cross-selling and AI-enabled productivity became the dominant proof points by Q3 and Q4.
Management framed Q1 as a strong start with progress integrating Paycor, cost synergy execution, and early cross-sell successes. AI was positioned as a differentiator (internal guidance and agentic pilots), while PEO retention remained strong despite Florida complexity.
Read earnings transcriptIn Q2, management highlighted productivity and expanding AI into operational systems, including agentic pilots with high accuracy. At the same time, management described softer revenue-per-client assumptions due to smaller deal sizes and lower upfront attachment, leading to outlook recalibration toward the low end of ranges.
Management provided multiple directional FY2026 guidance updates during Q1–Q3 and issued FY2027 ranges in Q4; transcript support for tight quarter-by-quarter guidance comparisons is limited.
FY2026 total revenue expected to grow between 16.5% and 18.5%.; FY2026 Management Solutions expected to grow 20% to 22%.; Adjusted diluted EPS expected to grow 9% to 11% (raised).
Revenue $6.51B (FY2026 revenue); Other $4.87B (FY2026 Management Solutions revenue); EPS $4.89
Q1 management reaffirmed FY2026 revenue growth range and raised EPS outlook, and FY2026 finished with strong revenue growth and EPS appreciation.
FY2026 total revenue expected to come in toward low end of ranges; reaffirmed.; Interest on funds held for clients expected toward high end of $190M to $200M range.; Adjusted diluted EPS expected to grow 10% to 11% (raised).
Revenue $6.51B (FY2026 revenue); Other $52M (Q4 interest on funds held for clients); EPS $4.89
Q2 guidance was recalibrated based on softer revenue-per-client inputs, but management still raised EPS growth expectations, aligning with full-year earnings strength.
Key forward-looking monitor items based on management’s recurring themes and Q&A focus.
Future growth durability depends on how fast Paychex monetizes ASO, PEO, and Retirement into the Paycor base.
Track broker-referred PEO/ASO deal flow, engagement rates, and “share of wallet” language next quarters.
Management is positioning WISE and agentic capabilities as a productivity and compliance differentiation driver that could affect margins and retention.
Monitor error reduction/turnaround metrics, agent scaling statements, and any revenue monetization examples for WISE.
AI execution
Across Q1–Q4, management expanded AI offerings from generative assistants and internal HR guidance to voice/email payroll agents and a growing agent ecosystem. In Q4, WISE was positioned as an intelligence engine embedded in workflows, with early administrative work reductions and measurable time savings.
PEO/health plan dynamics
Management repeatedly separated PEO durability from near-term insurance agency drag and Florida at-risk enrollment variability. Q2 and Q3 framed easier comps and enrollment timing; Q4 emphasized record worksite retention and better enrollment and medical attachment trends, supporting sequential organic acceleration.
Revenue model & pricing
Management consistently described a stable demand environment with customers “shopping” and choosing lower bundles or attaching fewer modules upfront, which softened revenue-per-client assumptions. Despite that, management highlighted product penetration, price realization, and fixed base fee components that protect downside employment fluctuations.
Broker-referred PEO wins and broker bookings rebounded into Q2.
Positive Bookings and broker referrals returned to pre-acquisition levels. |
Positive Enterprise success and synergy exceedances culminated in strong Q4. |
| Track broker pipeline and cross-sell attach pace into Paycor base next quarter. |
| AI scaled into workflows with human oversight | Positive Management expanded generative AI and piloted agentic tools in Q1. | Positive AI agents achieved near-100% accuracy on payroll calls and emails. | Positive Agent swarm scaled; WISE-like workflow adoption expanded across sales/service. | Positive WISE powered ~600 features/agents; measurable reductions in admin work. | Monitor WISE feature adoption, error-reduction metrics, and reported monetization pathways. |
| PEO remained sticky despite Florida enrollment noise | Mixed Florida attach rate framed as early and underwriting-sensitive. | Positive October enrollment met expectations; January enrollment early signals supported PEO. | Positive January enrollment progress and benefits intelligence improved sequential growth. | Positive Record worksite retention; medical enrollment up and agency drag reduced. | Watch enrollment timing (MPP), worksite retention, and insurance agency drag trend. |
| Shoppers stayed value-focused; fixed fees supported resilience | Neutral Management described stable demand amid micro softness pressures. | Mixed Revenue-per-client softer; smaller deal sizes and lower attachment. | Mixed Management cited sequential organic improvement and stable macro indicators. | Mixed Growth conviction tied to cross-sell and pricing/value realization tradeoffs. | Monitor module attachment and deal-size mix in Q1 selling season commentary. |
| Cost synergy and operating productivity became “behind us” then optimized | Positive Cost synergy target emphasized; management raised earnings expectation in Q1. | Positive Management expected ~$100M cost synergies and beat targets early. | Positive Expense synergy actions described as behind them; focus shifted to cross-sell. | Positive Exceeded synergy targets and highlighted ongoing procurement opportunities. | Track cost synergy realization rate versus AI/productivity reinvestment in FY2027. |
| Capital allocation and free cash flow reinforced the model | Positive Shareholder returns continued while management raised EPS outlook. | Positive Operating cash flow and buybacks reinforced margin/productivity narrative. | Positive Cash flow strength and a new buyback authorization supported confidence. | Positive FY2026 free cash flow and dividends/buybacks closed out strongly. | Monitor buyback pace and free cash flow margin alongside FY2027 revenue growth. |
Management emphasized a cost synergy target early, then stated actions were behind them by Q3 and that they exceeded FY2026 targets by Q4—shifting attention to procurement and investment tradeoffs.
Management repeatedly highlighted strong operating and free cash flow, and the FY2026 financials show resilient conversion with a high free cash flow margin, supporting capital returns through the year.
In Q2, management attributed softer revenue-per-client to smaller deal sizes and less attachment upfront, describing clients as cost-conscious shoppers selecting lower bundles.
Management characterized Florida as delicate due to underwriting/risk constraints and discussed easier compares after January enrollment in Q2 and Q3, culminating in improved attachment in Q4.
Management described the insurance agency as a drag on the overall PEO/insurance category in multiple quarters, with Q4 noting positive back-half trends but still persistent pressure.
Management repeatedly noted integration complexity and the difficulty of precisely segmenting Paycor recurring revenue and cross-sell effects into quarterly splits, affecting interpretation debates.
Scroll horizontally to see more columns.
| Quarter | Revenue | YoY revenue growth | Diluted EPS | Gross margin | Investor read |
|---|---|---|---|---|---|
| Q1Aug-25 | $1.54B | 7.9% | $1.06 | 73.1% | Integration momentum and early cross-sell wins offset some PEO softness and helped management lift earnings expectations. |
| Q2Nov-25 | $1.56B | 1.1% | $1.1 | 73.5% | Product penetration and price realization drove growth, while management flagged smaller deals and lower module attachment upfront. |
| Q3Feb-26 | $1.81B | 16.1% | $1.55 | 76.2% | Q3 served as the pivot: management described sequential organic improvement and stronger selling momentum heading toward Q4. |
| Q4May-26 | $1.61B | -11.2% | $1.17 | 74.0% | AI and cross-sell momentum were framed as durable, while FY2027 growth range depended on pricing/value and execution pacing. |
Q3 delivered revenue acceleration and operating margin strength, with management citing sequential improvement in organic growth aided by easier PEO enrollment comps. AI initiatives moved from pilots into scaling across sales and service, including voice/email agent payroll processing and compliance workflows.
Read earnings transcriptManagement closed FY2026 with strong Q4 momentum, exceeded Paycor synergy targets, and emphasized durable advisory differentiation supported by WISE. In Q4 Q&A, management reinforced that FY2027 growth conviction aligned with the organic exit trajectory, though float headwinds were noted.
Read earnings transcriptFY2026 outlook reaffirmed except raising interest on funds held for clients to $200M to $210M.; Q4 growth anticipated ~12% with adjusted operating margin 41% to 42%.
Revenue not_available; Other Adjusted operating margin 42.1% (Q4); revenue $1.61B (Q4)
Q3 provided specific Q4 margin expectations, and reported Q4 margins were consistent with the stated band, while revenue growth turned negative per quarter metric.
FY2027 total revenue growth range of 5% to 6%.; FY2027 adjusted operating income margin expected approximately 44%.; FY2027 adjusted diluted EPS expected to grow 7% to 9%.
Revenue not_available; Gross margin not_available; Other not_available
In Q4, management shifted from FY2026 execution to FY2027 ranges, but no FY2027 actuals were provided in the supplied dataset.
PEO/insurance growth path remains sensitive to enrollment timing and insurance agency headwinds, affecting quarter-to-quarter comparisons.
Watch Florida at-risk plan enrollment updates, medical attachment/renewal commentary, and agency drag trends next quarter.
Management attributed softer revenue-per-client to clients choosing fewer modules; persistence could affect earnings and guidance credibility.
Track module attachment at point of sale, deal-size mix commentary, and subsequent upsell or renewal pricing behavior.
Management described integration disruption as mostly behind them, but ongoing segmentation complexity can obscure how synergies flow.
Listen for clearer recurring revenue allocation explanations and whether performance aligns with “enterprise segment” framing.
Dafinchi